Recurrent primary sclerosing cholangitis: From an academic illusion to a clinical reality

Liver Transplantation

Volumn 11, Issue 11, 2005, Pages 1326-1328

  Abu Elmagd, Kareem M ^a   Balan, Vijayan ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID;

ALLOIMMUNITY; BILE DUCT OBSTRUCTION; BILE DUCT RECONSTRUCTION; CHOLANGIOGRAPHY; CHRONIC GRAFT REJECTION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG CHOICE; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE RISK; REPERFUSION INJURY; ROUX Y ANASTOMOSIS; THERAPY RESISTANCE; TREATMENT OUTCOME;

ACADEMIES AND INSTITUTES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CLINICAL MEDICINE; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; HUMANS; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MONITORING, PHYSIOLOGIC; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 30444436318     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20555     Document Type: Editorial

References (28)

1. Lerut J, Demetria AJ, Stieber AC, Marsh JW, Gordon RD, Esquivel CO, et al. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Transplant Int 1988;1:127-130.
2. Harrison R, Hubscher SG. Sclerosing cholangitis in liver allografts: A histological perspective. J Pathol 1992;176:150-152.
3. Harrison RF, Davis MH, Neuberger J, Hubscher S. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 1994;20:356-361.
4. Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999;29:1050-1056.
5. Abu-Elmagd K, Demetris AJ, Rakela J, Kang Y, Martin D, Dvorchik I, et al. Recurrence of primary sclerosing cholangitis (PSC) after hepatic transplantation (HTx): Single center experience with 380 grafts. Transplantation 1999;67:S236.
6. Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs. those with other liver diseases. AJR Am J Roentgenol 1993;161:297-300.
7. Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005;11:1361-1369.
8. Sheng R, Campbell WL, Zajko AB, Baron RL. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: Evidence of recurrent disease. AJR Am J Roentgenol 1996;166:1109-1113.
9. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, et al. Liver transplantation for primary sclerosing cholangitis: A long-term clinicopathologic study. Hum Pathol 2003;34:1127-1136.
10. Kubota T, Thomson A, Clouston AD, Nakazawa Y, Steadman C, Kerlin P, et al. Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation. J Hepatobiliary Pancreat Surg 1999;6:377-381.
11. Wiesner RH, Porayko MK, LaRusso NF, Ludwig J. Primary sclerosing cholangitis. In: Schiff L, Schiff ER, eds. Disease of the Liver. Vol. 1. 7th ed. Philadelphia, PA: Lippincott, 1993:411-426.
12. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-923.
13. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ. Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-877.
14. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process? Transplantation 1998;66:1300-1306.
15. Vera A, Moledina S, Gunson B, Hubscher S, Mirza D, Oliff S, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002;360:1943-1944.
16. Pappo o, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19:192-206.
17. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451.
18. Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225:472-481.
19. Neuberger J. Liver transplantation for cholestatic liver disease. Curr Treat Options Gastroenterol 2003;6:113-121.
20. Khettry U, Anand N, Faul PN, Lewis WD, Pomfret EA, Pomposelli J, et al. Liver transplantation for primary biliary cirrhosis: A long-term pathologic study. Liver Transplantation 2003;9:87-96.
21. van Buuren HR, van Hoogstraten HJ, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000;33:543-548.
22. Abdo AA, Bain VG, Kichian K, Lee SS. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology 2002;36:1393-1399.
23. Jaeckel E, Tillmann HL, Manns MP. Liver transplantation and autoimmunity. Acta Gastroenterol Belg 1999;62:323-329.
24. Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003;9:727-732.
25. Knechtler SJ, D'Allessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995;118:615.
26. Mandal A, Dasgupta A, Jeffers L, Squillante L, Hyder S, Reddy R. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 1994;106:185-192.
27. Dvorchik I, Subotin M, Demetris A, Fung J, Starzl T, Wieand S, Abu-Elmagd K. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosis cholangitis. Hepatology 2002;35:380-384.
28. Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 2002:359:150-157.